Target intelligence / Profile preview

Cholesterol side-chain cleavage enzyme (CYP11A1) (CYP11A1)

Target
CYP11A1
Molecular classification
Enzyme, Cytochrome P450 family, Mitochondrial enzyme
01

Overview

Adrenal cortex cell mitochondria enzyme systems refer to the mitochondrial enzymes within adrenal cortical cells that catalyze steroidogenesis, notably the conversion of cholesterol to pregnenolone (the first step in all steroid hormone biosynthesis) via cholesterol side-chain cleavage enzyme (CYP11A1, P450scc)[2][4][6]. Additional mitochondrial enzymes, such as CYP11B1 (11β-hydroxylase) and CYP11B2 (aldosterone synthase), participate in later steps for specific hormone production. These enzyme systems are critical for synthesizing cortisol, aldosterone, androgens; they are vital drug targets for modulating adrenal hormone output in conditions ranging from adrenal insufficiency to hypercortisolism. The entry as written is too broad, as it encompasses several enzymes rather than specifying an individual molecular target[2][6]. If structured data is required for a specific molecule, CYP11A1 (cholesterol side-chain cleavage enzyme) is the proper, specific target name for adrenal mitochondrial steroidogenesis. For other steroidogenic steps, CYP11B1 (11β-hydroxylase) or CYP11B2 (aldosterone synthase) would be named analogously[2][4][6].

Other names
Cholesterol side-chain cleavage enzymeSide-chain cleavage enzymeCytochrome P450sccCYP11A1Mitochondrial cytochrome P450 enzymes
02

Mechanism of action

Inhibition of steroid hormone biosynthesis via CYP enzyme inhibition[2][4][6] Enzyme blockade (preventing conversion of cholesterol to pregnenolone/cortisol/aldosterone[2][6])

03

Biological functions

Steroidogenesis (biosynthesis of steroid hormones from cholesterol[2][1][4][6])Hormone production (glucocorticoids, mineralocorticoids, androgens[2][4][5])Signal transduction (as part of endocrine regulation[2])
04

Disease associations

Adrenal insufficiency (e.g., congenital adrenal hyperplasia[2][6])Steroid hormone deficiency syndromesCushing's syndromeOther endocrine disorders[2][6]
05

Safety considerations

Risk of adrenal insufficiency (when inhibitors block essential steroid hormone synthesis[6])Hormonal imbalanceOff-target effects when inhibiting adrenal mitochondrial enzymes
06

Interacting drugs

Ketoconazole (CYP inhibitor used to block adrenal steroidogenesis[2][6])

2 more in the full profile.

07

Biomarkers

Circulating steroid hormone levels (cortisol, aldosterone, DHEA[2][4])ACTH stimulation test (to assess adrenal corticosteroid output[4][6])

Beyond the preview

Go deeper on Cholesterol side-chain cleavage enzyme (CYP11A1) (CYP11A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cholesterol side-chain cleavage enzyme (CYP11A1) (CYP11A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call